Cardinal Health 414
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Cardinal Health 414 sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).
Cardinal Health 414: 2 sponsored US clinical trials, none currently recruiting.
Cardinal Health 414 sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rhabdomyosarcoma, with 1 trials.
Mid-pack sponsor footprint
Cardinal Health 414 is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Indexed trials (enrollment closed)
2 total, page 1 of 1
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
NCT02509585
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
NCT02509598
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
How the Cardinal Health 414 early-phase archive is shaped
2 indexed studies, none listed as recruiting (0% open); 1 completed (50%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Rhabdomyosarcoma (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cardinal Health 414: archived-pipeline peers nationwide
Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cardinal Health 414 sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 2 archived trials
- 1200 Pharma · 2 trials · 50% recruiting
- 1ST Biotherapeutics · 2 trials · 50% recruiting
- 3 Waves Wellness · 2 trials · 0% recruiting
- 3EO Health · 2 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Cardinal Health 414 page
2 registered trials is a research-attention snapshot, not an endorsement of Cardinal Health 414 or any single study.
- None of Cardinal Health 414's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Rhabdomyosarcoma is the condition Cardinal Health 414 studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rhabdomyosarcoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cardinal Health 414 pipeline card: 2 registered trials from official public datasets.Report a data error.